10 healthcare leaders on LinkedIn's Next Wave list of young professionals

LinkedIn released the 2016 LinkedIn Next Wave, its second annual compilation of innovative individuals 35 and under.

The 120 names on this year's list reflect risk-takers from a number of industries, including technology, food and leisure, media, VC and finance, healthcare, education, retail, entertainment, marketing and social media, government, social impact and software. LinkedIn's selection methodology involved narrowing down its 450 million member network, consulting LinkedIn Influencers and polling 2015 Next Wavers to see who they follow.

Here are the 10 healthcare leaders on the 2016 LinkedIn Next Wave list.

  • Elizabeth Asai, CEO of 3Derm Systems. Ms. Asai, 25, founded 3Derm while attending New Haven, Conn.-based Yale University. Through the company's technology, primary care physicians can take 3-D images of patients' skin and send them to other clinicians for remote diagnoses.
  • Zoe Barry, founder and CEO of ZappRx. After her brother was diagnosed with epilepsy, Ms. Barry, 31, founded ZappRx in 2012. ZappRx speeds up the prescribing process by utilizing a secure, digital platform.
  • Josh Bruno, cofounder and CEO of Hometeam. Cofounded by 29-year-old Mr. Bruno, Hometeam's software helps America's growing number of senior citizens live independently. Hometeam, which hopes to expand to cities across the nation by 2017, counts Oakland, Calif.-based Kaiser Permanente among its investors.
  • Geoffrey Chaiken, cofounder and CEO of Blink Health. Two years ago, Mr. Chaiken, 34, and his brother Matthew, 30, founded Blink Health, a pharmacy benefit manager. This isn't the first company Geoffrey founded — he launched Marinus Pharmaceuticals as a student at Yale.
  • Sean Duffy, cofounder and CEO of Omada Health. Thirty-two-year-old Mr. Duffy leads Omada Health, a digital health platform that helps companies identify its at-risk employees and keep them healthy. As of this year, Omada can count the American Medical Association as one of its investors.
  • Rachel Haurwitz, PhD, CEO of Caribou Biosciences. Dr. Haurwitz, 31, began working on clustered regularly interspaced short palindromic repeats (CRISPR) technology — a gene-editing tool — while conducting doctorate work at the University of California, Berkeley. She now heads up Caribou Biosciences, which is working to commercialize CRISPR technology.
  • David Mou, MD, cofounder and medical director of Valera Health. Tech company Valera Health works to address mental illness by identifying people who are at risk for acute psychotic episodes. In addition to cofounding the company with Thomas Tsang, MD, and Ofer Sharon, MD, Dr. Mou, 30, now helps conduct medical research for Valera.
  • Loren Robinson, MD, deputy secretary for health promotion at the Pennsylvania Department of Health. The Pennsylvania Department of Health created Dr. Robinson's current role in 2015. Now, the 35-year-old practicing internist and pediatrician is working to address the social determinants of health,  particularly in the state's rural communities.
  • Mandira Singh, director of More Disruption Please at athenahealth. Ms. Singh, who trained as an opera singer in college, runs athenahealth's More Disruption Please program, which provides innovators with access to athenahealth's 80,000-provider client base. The 31-year-old also heads up the company's investment program in early-stage digital health companies.
  • Mark Smith, PhD, cofounder and research director of OpenBiome. One way to cure Clostridium difficile is to introduce healthy bacteria in the form of a fecal transplant. Dr. Smith, 29, cofounded OpenBiome to help C. diff sufferers find donors. The company, which screens potential donors and processes samples, recently treated its 15,000th patient.

Click here to view the 2016 LinkedIn Next Wave list in its entirety.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Articles We Think You'll Like

 

Featured Whitepapers

Featured Webinars